Abiopharma

🔍 Harris Andee (Director)

Company: Lifeway Foods, Inc. (LWAY)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 873 shares of Phantom Stock (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 873.00 | transaction_form_type: 4 | Footnotes: F3, F4, F3, F3
• Holds 2,512 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 2,512.00 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
• F2: The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date.
• F3: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
• F4: The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended March 31, 2026 pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan.